SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-QSB
(Mark One)
[X] Quarterly report under Section 13 or 15(d) of the Securities Exchange
Act of 1934 for the quarterly period ended March 31, 2000.
[ ] Transition report under Section 13 or 15(d) of the Securities Exchange
Act of 1934 for the transition period from ________ to ________.
Commission file number: 0-29383
-------
CYBERBOTANICAL, INC.
-----------------------------------------------------------------
(Exact name of small business issuer as specified in its charter)
Nevada 88-0356200
------ ----------
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
268 West 400 South, Suite 300, Salt Lake City, Utah 84101
---------------------------------------------------------
(Address of principal executive office) (Zip Code)
(801) 575-8073
---------------------------
(Issuer's telephone number)
Check whether the issuer: (1) filed all reports required to be filed by Section
13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days.
Yes______ No XX
The number of outstanding shares of the issuer's common stock, $0.001 par value
(the only class of voting stock), as of May 12, 2000 was 2,042,000.
<PAGE>
TABLE OF CONTENTS
PART I
ITEM 1. FINANCIAL STATEMENTS..................................................3
Unaudited Balance Sheet as of March 31, 2000 and December 31, 1999.............4
Unaudited Statement of Operations for the three months ended March 31, 2000
and 1999 and February 15, 1996 (Date of Inception) to March 31, 2000...........5
Unaudited Statement of Cash Flows for the three months ended March 31, 2000
and 1999 and February 15, 1996 (Date of Inception) to December 31, 1999........6
Notes to Condensed Financial Statements........................................7
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION.............8
PART II
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K......................................8
SIGNATURES.....................................................................9
INDEX TO EXHIBITS.............................................................10
[THIS SPACE HAS BEEN INTENTIONALLY LEFT BLANK]
2
<PAGE>
PART I
ITEM 1. FINANCIAL STATEMENTS
As used herein, the term "Company" refers to Cyberbotanical Inc., a Nevada
corporation, and its subsidiaries and predecessors unless otherwise indicated.
Consolidated, unaudited, condensed interim financial statements including a
balance sheet for the Company as of the quarter ended March 31, 2000 and
statements of operations, statements of shareholders equity and statements of
cash flows for the interim period up to the date of such balance sheet and the
comparable period of the preceding year are attached hereto as Pages 4 through 7
and are incorporated herein by this reference.
[THIS SPACE HAS BEEN LEFT BLANK INTENTIONALLY]
3
<PAGE>
CYBERBOTANICAL, INC.
(A Development Stage Company)
Balance Sheets
As of March 31, 2000 and December 31, 1999
<TABLE>
<CAPTION>
(Unaudited)
March 31, December
2000 31, 1999
-------------- --------------
ASSETS
<S> <C> <C>
CURRENT ASSETS:
Cash $ 411 $ -
Stock subscription receivable - $ 360
-------------- --------------
TOTAL CURRENT ASSETS 411 360
TOTAL ASSETS $ 411 $ 360
============== ==============
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES:
Accounts Payable - Related Party 1,010 -
-------------- --------------
TOTAL CURRENT LIABILITIES 1,010 -
STOCKHOLDERS' EQUITY:
Preferred stock, $.001 par value; authorized 5,000,000 shares; no
shares issued - -
Common stock, $.001 par value; authorized 20,000,000 shares;
shares issued and outstanding: 2,042,000 on March 31, 2000 and
December 31, 1999 2,042 2,042
Additional paid-in capital 324 324
Accumulated deficit during development stage (2,965) (2,006)
-------------- --------------
TOTAL STOCKHOLDERS' EQUITY (599) 360
-------------- --------------
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 411 $ 360
============== ==============
</TABLE>
The accompanying notes are an integral part of these financial statements
4
<PAGE>
CYBERBOTANICAL, INC.
(A Development Stage Company)
Unaudited Statements of Operations
For the Three Months Ended March 31, 2000 and 1999 and
February 15, 1996 (Date of Inception) to March 31, 2000
<TABLE>
<CAPTION>
March 31, March 31, Inception to
2000 1999 March 31, 2000
--------------- ---------------- -------------------
<S> <C> <C> <C>
Revenue:
None $ - $ - $ -
--------------- ---------------- -------------------
Expenses:
General and administrative costs - - 2,006
Accounting 709 - 709
Stock Related 250 - 250
--------------- ---------------- -------------------
Gross Expenses 959 - 2965
Operating Profit (Loss) (959) - (2,965)
--------------- ---------------- -------------------
Provision for income taxes - - -
Net loss $ (959)$ - $ (2,965)
=============== ================ ===================
Net loss per common share - basic $ - $ - $ -
=============== ================ ===================
Weighted average number of shares outstanding - basic 1,042,822 1,000,000 -
=============== ================ ===================
</TABLE>
The accompanying notes are an integral part of these financial statements
5
<PAGE>
CYBERBOTANICAL, INC.
(A Developmental Stage Company)
Unaudited Statements of Cash Flows
For the Three Months Ended March 31, 2000 and 1999 and
February 15, 1996 (Date of Inception) to December 31, 1999
<TABLE>
<CAPTION>
February 15,
1996 (Inception)
March 31, March 31, to March 31,
2000 1999 2000
--------------- --------------- -----------------
CASH FLOWS FROM OPERATING ACTIVITIES:
<S> <C> <C> <C>
Net (loss) $ (959) $ - $ (2,965)
--------------- --------------- -----------------
Adjustments to reconcile net (loss) to net
cash used by operating activities:
Services and expenses paid with common stock - - 1,006
--------------- --------------- -----------------
Total adjustments - - 1,006
--------------- --------------- -----------------
Net cash provided (used) by operating activities (959) - (1,959)
--------------- --------------- -----------------
CASH FLOWS FROM FINANCING ACTIVITIES:
Loans by Related Party 1,010 - 1,010
Capital contributions by incorporators 360 - 1,360
--------------- --------------- -----------------
Net cash provided by financing activities 1,370 - 2,370
Net increase in cash 411 - 411
--------------- --------------- -----------------
Cash, beginning - - -
--------------- --------------- -----------------
Cash, ending $ 411 $ - $ 411
=============== =============== =================
SUPPLEMENTAL SCHEDULE OF NON-CASH
INVESTING AND FINANCING ACTIVITIES:
Issuance of common stock for services and expenses $ - $ - $ 1,006
=============== =============== =================
</TABLE>
The accompanying notes are an integral part of these financial statements
6
<PAGE>
CYBERBOTANICAL, INC
NOTES TO CONSOLIDATED UNAUDITED FINANCIAL STATEMENTS
March 31, 2000
1. Basis of Presentation
The accompanying consolidated unaudited condensed financial statements have been
prepared by management in accordance with the instructions in Form 10-QSB and,
therefore, do not include all information and footnotes required by generally
accepted accounting principles and should, therefore, be read in conjunction
with the Company's initial registration statement on Form 10-SB, filed with the
Securities and Exchange Commission on February 8, 2000. These statements do
include all normal recurring adjustments which the Company believes necessary
for a fair presentation of the statements. The interim operations results are
not necessarily indicative of the results for the full year ended December 31,
2000.
2. Year 2000 Compliance
As of May 12, 2000 the Company has not had or become aware of any significant
problems associated with Year 2000 issues.
3. Additional footnotes included by reference
Except as indicated in Notes above, there have been no other material changes in
the information disclosed in the notes to the financial statements included in
the Company's initial registration statement on Form 10-SB, filed with the
Securities and Exchange Commission on February 8, 2000. Therefore, those
footnotes are included herein by reference.
7
<PAGE>
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION
Plan of Operations
The Company's plan of operation for the coming year is to identify and acquire a
favorable business opportunity. The Company does not plan to limit its options
to any particular industry, but will evaluate each opportunity on its merits.
The Company anticipates that its owners, affiliates, and consultants will
provide it with sufficient capital to continue operations until the end of the
second quarter of 2000, but there can be no assurance that this expectation will
be fully realized.
The Company does not expect to generate any meaningful revenue or incur
operating expenses unless and until it acquires an interest in an operating
company.
PART II
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K
(a) Exhibits Exhibits required to be attached by Item 601 of Regulation S-B are
listed in the Index to Exhibits on page 10 of this Form 10-QSB, and are
incorporated herein by this reference.
(b) Reports on Form 8-K. No reports on Form 8-K were filed during the period
covered by this Form 10- QSB.
[THIS SPACE HAS BEEN LEFT BLANK INTENTIONALLY]
8
<PAGE>
SIGNATURES
In accordance with the requirements of the Exchange Act, the registrant caused
this report to be signed on its behalf by the undersigned, hereunto duly
authorized, this 12th day of May, 2000.
CYBERBOTANICAL, INC.
Signature Date
- --------- ----
/s/ Richard Surber May 12, 2000
- -----------------------
Richard Surber
President and Director
[THIS SPACE HAS BEEN LEFT BLANK INTENTIONALLY]
9
<PAGE>
INDEX TO EXHIBITS
EXHIBIT PAGE
NO. NO. DESCRIPTION
- ------- ---- -----------
3(i) * Articles of Incorporation of the Company (incorporated
herein by reference from Exhibit No. 3(i) of the Company's
Form 10-SB as filed with the Securities and Exchange
Commission on February 8, 2000).
3(ii) * Bylaws of the Company, as amended (incorporated herein by
reference from Exhibit 3(ii) of the Company's Form 10-SB as
filed with the Securities and Exchange Commission on
February 8, 2000).
[THIS SPACE HAS BEEN LEFT BLANK INTENTIONALLY]
10
<PAGE>
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM CONSOLIDATED
UNAUDITED CONDENSED FINANCIAL STATEMENTS FILED WITH THE COMPANY'S MARCH 31,
2000, QUARTERLY REPORT ON FORM 10-QSB AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<CIK> 0001016069
<NAME> Cyberbotanical, Inc.
<MULTIPLIER> 1
<CURRENCY> U.S. Dollars
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-END> MAR-31-2000
<EXCHANGE-RATE> 1
<CASH> 411
<SECURITIES> 0
<RECEIVABLES> 0
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 411
<PP&E> 0
<DEPRECIATION> 0
<TOTAL-ASSETS> 411
<CURRENT-LIABILITIES> 1,010
<BONDS> 0
0
0
<COMMON> 2,042
<OTHER-SE> (2,641)
<TOTAL-LIABILITY-AND-EQUITY> 411
<SALES> 0
<TOTAL-REVENUES> 0
<CGS> 0
<TOTAL-COSTS> 0
<OTHER-EXPENSES> 959
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> (959)
<INCOME-TAX> 0
<INCOME-CONTINUING> (959)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (959)
<EPS-BASIC> (0.00)
<EPS-DILUTED> (0.00)
</TABLE>
